Table of Contents Author Guidelines Submit a Manuscript
Stem Cells International
Volume 2016 (2016), Article ID 3140120, 15 pages
http://dx.doi.org/10.1155/2016/3140120
Review Article

In Vivo Tracking of Cell Therapies for Cardiac Diseases with Nuclear Medicine

1Departamento de Radiologia, Faculdade de Medicina, Universidade Federal do Rio de Janeiro, 21941-913 Rio de Janeiro, RJ, Brazil
2Instituto de Ciências Biomédicas, Universidade Federal do Rio de Janeiro, 21941-902 Rio de Janeiro, RJ, Brazil

Received 9 August 2015; Revised 18 October 2015; Accepted 20 October 2015

Academic Editor: Renke Li

Copyright © 2016 Mayra Lorena Moreira et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. C. J. L. Murray, T. Vos, R. Lozano et al., “Disability-adjusted life years (DALYs) for 291 diseases and injuries in 21 regions, 1990–2010: a systematic analysis for the Global Burden of Disease Study 2010,” The Lancet, vol. 380, no. 9859, pp. 2197–2223, 2013. View at Publisher · View at Google Scholar
  2. R. Lozano, M. Naghavi, K. Foreman et al., “Global and regional mortality from 235 causes of death for 20 age groups in 1990 and 2010: a systematic analysis for the Global Burden of Disease Study 2010,” The Lancet, vol. 380, no. 9859, pp. 2095–2128, 2012. View at Publisher · View at Google Scholar
  3. V. F. M. Segers and R. T. Lee, “Stem-cell therapy for cardiac disease,” Nature, vol. 451, no. 7181, pp. 937–942, 2008. View at Publisher · View at Google Scholar · View at Scopus
  4. S. A. A. Fisher, C. Doree, A. Mathur, and E. Martin-Rendon, “Meta-analysis of cell therapy trials for patients with heart failure,” Circulation Research, vol. 116, no. 8, pp. 1361–1377, 2015. View at Publisher · View at Google Scholar · View at Scopus
  5. M. R. Rosen, R. J. Myerburg, D. P. Francis, G. D. Cole, and E. Marbán, “Translating stem cell research to cardiac disease therapies: pitfalls and prospects for improvement,” Journal of the American College of Cardiology, vol. 64, no. 9, pp. 922–937, 2014. View at Publisher · View at Google Scholar · View at Scopus
  6. A. Behfar, R. Crespo-Diaz, A. Terzic, and B. J. Gersh, “Cell therapy for cardiac repair-lessons from clinical trials,” Nature Reviews Cardiology, vol. 11, no. 4, pp. 232–246, 2014. View at Publisher · View at Google Scholar · View at Scopus
  7. A. T. Chan and M. R. Abraham, “SPECT and PET to optimize cardiac stem cell therapy,” Journal of Nuclear Cardiology, vol. 19, no. 1, pp. 118–125, 2012. View at Publisher · View at Google Scholar · View at Scopus
  8. A. Ruggiero, D. L. J. Thorek, J. Guenoun, G. P. Krestin, and M. R. Bernsen, “Cell tracking in cardiac repair: what to image and how to image,” European Radiology, vol. 22, no. 1, pp. 189–204, 2012. View at Publisher · View at Google Scholar · View at Scopus
  9. C. J. Palestro, C. Love, and K. K. Bhargava, “Labeled leukocyte imaging: current status and future directions,” Quarterly Journal of Nuclear Medicine and Molecular Imaging, vol. 53, no. 1, pp. 105–123, 2009. View at Google Scholar · View at Scopus
  10. B. Gutfilen, S. A. L. de Souza, F. P. P. Martins, L. R. Cardoso, M. C. P. Pessoa, and L. M. B. Fonseca, “Use of 99mTc-mononuclear leukocyte scintigraphy in nosocomial fever,” Acta Radiologica, vol. 47, no. 7, pp. 699–704, 2006. View at Publisher · View at Google Scholar · View at Scopus
  11. G. Mariani, L. Bruselli, T. Kuwert et al., “A review on the clinical uses of SPECT/CT,” European Journal of Nuclear Medicine and Molecular Imaging, vol. 37, no. 10, pp. 1959–1985, 2010. View at Publisher · View at Google Scholar · View at Scopus
  12. C. Wu, G. Ma, J. Li et al., “In vivo cell tracking via 18F-fluorodeoxyglucose labeling: a review of the preclinical and clinical applications in cell-based diagnosis and therapy,” Clinical Imaging, vol. 37, no. 1, pp. 28–36, 2013. View at Publisher · View at Google Scholar · View at Scopus
  13. C. Rischpler, A. Paschali, C. Anagnostopoulos, and S. G. Nekolla, “Cardiac PET for translational imaging,” Current Cardiology Reports, vol. 17, no. 5, p. 28, 2015. View at Publisher · View at Google Scholar
  14. A. Bansal, M. K. Pandey, Y. E. Demirhan et al., “Novel 89Zr cell labeling approach for PET-based cell trafficking studies,” EJNMMI Research, vol. 5, article 19, 2015. View at Publisher · View at Google Scholar
  15. H. Hong, Y. Yang, Y. Zhang, and W. Cai, “Non-invasive cell tracking in cancer and cancer therapy,” Current Topics in Medicinal Chemistry, vol. 10, no. 12, pp. 1237–1248, 2010. View at Publisher · View at Google Scholar · View at Scopus
  16. P. H. Rosado-de-Castro, P. M. Pimentel-Coelho, B. Gutfilen et al., “Radiopharmaceutical stem cell tracking for neurological diseases,” BioMed Research International, vol. 2014, Article ID 417091, 12 pages, 2014. View at Publisher · View at Google Scholar · View at Scopus
  17. S. S. Yaghoubi, D. O. Campbell, C. G. Radu, and J. Czernin, “Positron emission tomography reporter genes and reporter probes: gene and cell therapy applications,” Theranostics, vol. 2, no. 4, pp. 374–391, 2012. View at Publisher · View at Google Scholar · View at Scopus
  18. A. R. Penheiter, S. J. Russell, and S. K. Carlson, “The sodium iodide symporter (NIS) as an imaging reporter for gene, viral, and cell-based therapies,” Current Gene Therapy, vol. 12, no. 1, pp. 33–47, 2012. View at Publisher · View at Google Scholar · View at Scopus
  19. W. Brenner, A. Aicher, T. Eckey et al., “111In-labeled CD34+ hematopoietic progenitor cells in a rat myocardial infarction model,” Journal of Nuclear Medicine, vol. 45, no. 3, pp. 512–518, 2004. View at Google Scholar · View at Scopus
  20. A. Gholamrezanezhad, S. Mirpour, J. M. Ardekani et al., “Cytotoxicity of 111In-oxine on mesenchymal stem cells: a time-dependent adverse effect,” Nuclear Medicine Communications, vol. 30, no. 3, pp. 210–216, 2009. View at Publisher · View at Google Scholar · View at Scopus
  21. F. J. Gildehaus, F. Haasters, I. Drosse et al., “Impact of indium-111 oxine labelling on viability of human mesenchymal stem cells in vitro, and 3D cell-tracking using SPECT/CT in vivo,” Molecular Imaging and Biology, vol. 13, no. 6, pp. 1204–1214, 2011. View at Publisher · View at Google Scholar · View at Scopus
  22. Y. Jin, H. Kong, R. Z. Stodilka et al., “Determining the minimum number of detectable cardiac-transplanted 111In-tropolone-labelled bone-marrow-derived mesenchymal stem cells by SPECT,” Physics in Medicine and Biology, vol. 50, no. 19, pp. 4445–4455, 2005. View at Publisher · View at Google Scholar · View at Scopus
  23. G. D. Suhett, S. A. de Souza, A. B. Carvalho et al., “99m-Technetium binding site in bone marrow mononuclear cells,” Stem Cell Research & Therapy, vol. 6, article 115, 2015. View at Publisher · View at Google Scholar
  24. E. Wolfs, T. Struys, T. Notelaers et al., “18F-FDG labeling of mesenchymal stem cells and multipotent adult progenitor cells for PET imaging: effects on ultrastructure and differentiation capacity,” Journal of Nuclear Medicine, vol. 54, no. 3, pp. 447–454, 2013. View at Publisher · View at Google Scholar · View at Scopus
  25. Y. Zhang, J. N. da Silva, T. Hadizad et al., “18F-FDG cell labeling may underestimate transplanted cell homing: more accurate, efficient, and stable cell labeling with hexadecyl-4-[18F]fluorobenzoate for in vivo tracking of transplanted human progenitor cells by positron emission tomography,” Cell Transplantation, vol. 21, no. 9, pp. 1821–1835, 2012. View at Publisher · View at Google Scholar · View at Scopus
  26. K. J. Blackwood, B. Lewden, R. G. Wells et al., “In vivo SPECT quantification of transplanted cell survival after engraftment using 111In-tropolone in infarcted canine myocardium,” Journal of Nuclear Medicine, vol. 50, no. 6, pp. 927–935, 2009. View at Publisher · View at Google Scholar · View at Scopus
  27. M. E. Danoviz, J. S. Nakamuta, F. L. N. Marques et al., “Rat adipose tissue-derived stem cells transplantation attenuates cardiac dysfunction post infarction and biopolymers enhance cell retention,” PLoS ONE, vol. 5, no. 8, Article ID e12077, 2010. View at Publisher · View at Google Scholar · View at Scopus
  28. M. M. Welling, M. Duijvestein, A. Signore, and L. van der Weerd, “In vivo biodistribution of stem cells using molecular nuclear medicine imaging,” Journal of Cellular Physiology, vol. 226, no. 6, pp. 1444–1452, 2011. View at Publisher · View at Google Scholar · View at Scopus
  29. M. Welling, H. I. J. Feitsma, D. Blok et al., “A new 99mTc labelling method for leucocytes: in vitro and in vivo comparison with 99mTc-HMPAO,” Quarterly Journal of Nuclear Medicine, vol. 39, no. 2, pp. 89–98, 1995. View at Google Scholar · View at Scopus
  30. D. L. Kraitchman, M. Tatsumi, W. D. Gilson et al., “Dynamic imaging of allogeneic mesenchymal stem cells trafficking to myocardial infarction,” Circulation, vol. 112, no. 10, pp. 1451–1461, 2005. View at Publisher · View at Google Scholar · View at Scopus
  31. M. Lutz, M. Rosenberg, F. Kiessling et al., “Local injection of stem cell factor (SCF) improves myocardial homing of systemically delivered c-kit+ bone marrow-derived stem cells,” Cardiovascular Research, vol. 77, no. 1, pp. 143–150, 2008. View at Publisher · View at Google Scholar · View at Scopus
  32. V. N. S. Garikipati, S. Jadhav, L. Pal, P. Prakash, M. Dikshit, and S. Nityanand, “Mesenchymal stem cells from fetal heart attenuate myocardial injury after infarction: an in vivo serial pinhole gated SPECT-CT study in rats,” PLoS ONE, vol. 9, no. 6, Article ID e100982, 2014. View at Publisher · View at Google Scholar · View at Scopus
  33. A. Aicher, W. Brenner, M. Zuhayra et al., “Assessment of the tissue distribution of transplanted human endothelial progenitor cells by radioactive labeling,” Circulation, vol. 107, no. 16, pp. 2134–2139, 2003. View at Publisher · View at Google Scholar · View at Scopus
  34. I. M. Barbash, P. Chouraqui, J. Baron et al., “Systemic delivery of bone marrow-derived mesenchymal stem cells to the infarcted myocardium: feasibility, cell migration, and body distribution,” Circulation, vol. 108, no. 7, pp. 863–868, 2003. View at Publisher · View at Google Scholar · View at Scopus
  35. R. Zhou, D. H. Thomas, H. Qiao et al., “In vivo detection of stem cells grafted in infarcted rat myocardium,” Journal of Nuclear Medicine, vol. 46, no. 5, pp. 816–822, 2005. View at Google Scholar · View at Scopus
  36. D. Shen, D. Liu, Z. Cao, P. D. Acton, and R. Zhou, “Coregistration of magnetic resonance and single photon emission computed tomography images for noninvasive localization of stem cells grafted in the infarcted rat myocardium,” Molecular Imaging and Biology, vol. 9, no. 1, pp. 24–31, 2007. View at Publisher · View at Google Scholar · View at Scopus
  37. N. Tran, S. Poussier, P. R. Franken et al., “Feasibility of in vivo dual-energy myocardial SPECT for monitoring the distribution of transplanted cells in relation to the infarction site,” European Journal of Nuclear Medicine and Molecular Imaging, vol. 33, no. 6, pp. 709–715, 2006. View at Publisher · View at Google Scholar · View at Scopus
  38. N. Tran, Y. Li, F. Maskali et al., “Short-term heart retention and distribution of intramyocardial delivered mesenchymal cells within necrotic or intact myocardium,” Cell Transplantation, vol. 15, no. 4, pp. 351–358, 2006. View at Publisher · View at Google Scholar · View at Scopus
  39. N. Tran, P. R. Franken, F. Maskali et al., “Intramyocardial implantation of bone marrow-derived stem cells enhances perfusion in chronic myocardial infarction: dependency on initial perfusion depth and follow-up assessed by gated pinhole SPECT,” Journal of Nuclear Medicine, vol. 48, no. 3, pp. 405–412, 2007. View at Google Scholar · View at Scopus
  40. G. Wisenberg, K. Lekx, P. Zabel et al., “Cell tracking and therapy evaluation of bone marrow monocytes and stromal cells using SPECT and CMR in a canine model of myocardial infarction,” Journal of Cardiovascular Magnetic Resonance, vol. 11, article 11, 2009. View at Publisher · View at Google Scholar · View at Scopus
  41. J. Terrovitis, R. Lautamäki, M. Bonios et al., “Noninvasive quantification and optimization of acute cell retention by in vivo positron emission tomography after intramyocardial cardiac-derived stem cell delivery,” Journal of the American College of Cardiology, vol. 54, no. 17, pp. 1619–1626, 2009. View at Publisher · View at Google Scholar · View at Scopus
  42. C. Lang, S. Lehner, A. Todica et al., “Positron emission tomography based in-vivo imaging of early phase stem cell retention after intramyocardial delivery in the mouse model,” European Journal of Nuclear Medicine and Molecular Imaging, vol. 40, no. 11, pp. 1730–1738, 2013. View at Publisher · View at Google Scholar · View at Scopus
  43. C. Lang, S. Lehner, A. Todica et al., “In-vivo comparison of the acute retention of stem cell derivatives and fibroblasts after intramyocardial transplantation in the mouse model,” European Journal of Nuclear Medicine and Molecular Imaging, vol. 41, no. 12, pp. 2325–2336, 2014. View at Publisher · View at Google Scholar · View at Scopus
  44. A. J. Mitchell, E. Sabondjian, J. Sykes et al., “Comparison of initial cell retention and clearance kinetics after subendocardial or subepicardial injections of endothelial progenitor cells in a canine myocardial infarction model,” Journal of Nuclear Medicine, vol. 51, no. 3, pp. 413–417, 2010. View at Publisher · View at Google Scholar · View at Scopus
  45. A. J. Mitchell, E. Sabondjian, K. J. Blackwood et al., “Comparison of the myocardial clearance of endothelial progenitor cells injected early versus late into reperfused or sustained occlusion myocardial infarction,” The International Journal of Cardiovascular Imaging, vol. 29, no. 2, pp. 497–504, 2013. View at Publisher · View at Google Scholar · View at Scopus
  46. E. Sabondjian, A. J. Mitchell, G. Wisenberg et al., “Hybrid SPECT/cardiac-gated first-pass perfusion CT: locating transplanted cells relative to infarcted myocardial targets,” Contrast Media and Molecular Imaging, vol. 7, no. 1, pp. 76–84, 2012. View at Publisher · View at Google Scholar · View at Scopus
  47. P. Maureira, P.-Y. Marie, Y. Liu et al., “Sustained therapeutic perfusion outside transplanted sites in chronic myocardial infarction after stem cell transplantation,” International Journal of Cardiovascular Imaging, vol. 29, no. 4, pp. 809–817, 2013. View at Publisher · View at Google Scholar · View at Scopus
  48. M. H. Kim, S.-K. Woo, K. C. Lee et al., “Longitudinal monitoring adipose-derived stem cell survival by PET imaging hexadecyl-4-124I-iodobenzoate in rat myocardial infarction model,” Biochemical and Biophysical Research Communications, vol. 456, no. 1, pp. 13–19, 2015. View at Publisher · View at Google Scholar · View at Scopus
  49. E. Elhami, B. Dietz, B. Xiang et al., “Assessment of three techniques for delivering stem cells to the heart using PET and MR imaging,” EJNMMI Research, vol. 3, no. 1, article 72, 2013. View at Publisher · View at Google Scholar · View at Scopus
  50. H. Qian, Y. Yang, J. Huang et al., “Intracoronary delivery of autologous bone marrow mononuclear cells radiolabeled by 18F-fluoro-deoxy-glucose: tissue distribution and impact on post-infarct swine hearts,” Journal of Cellular Biochemistry, vol. 102, no. 1, pp. 64–74, 2007. View at Publisher · View at Google Scholar · View at Scopus
  51. B. Doyle, B. J. Kemp, P. Chareonthaitawee et al., “Dynamic tracking during intracoronary injection of 18F-FDG-labeled progenitor cell therapy for acute myocardial infarction,” Journal of Nuclear Medicine, vol. 48, no. 10, pp. 1708–1714, 2007. View at Publisher · View at Google Scholar · View at Scopus
  52. M. C. Keith, Y. Tokita, X. Tang et al., “Effect of the stop-flow technique on cardiac retention of c-kit positive human cardiac stem cells after intracoronary infusion in a porcine model of chronic ischemic cardiomyopathy,” Basic Research in Cardiology, vol. 110, article 46, 2015. View at Publisher · View at Google Scholar
  53. P. Tossios, B. Krausgrill, M. Schmidt et al., “Role of balloon occlusion for mononuclear bone marrow cell deposition after intracoronary injection in pigs with reperfused myocardial infarction,” European Heart Journal, vol. 29, no. 15, pp. 1911–1921, 2008. View at Publisher · View at Google Scholar · View at Scopus
  54. J. Mäkelä, V. Anttila, K. Ylitalo et al., “Acute homing of bone marrow-derived mononuclear cells in intramyocardial vs. intracoronary transplantation,” Scandinavian Cardiovascular Journal, vol. 43, no. 6, pp. 366–373, 2009. View at Publisher · View at Google Scholar · View at Scopus
  55. V. F. Forest, A. M. Tirouvanziam, C. Perigaud et al., “Cell distribution after intracoronary bone marrow stem cell delivery in damaged and undamaged myocardium: implications for clinical trials,” Stem Cell Research and Therapy, vol. 1, no. 1, article 4, 2010. View at Publisher · View at Google Scholar · View at Scopus
  56. S. J. Zhang and J. C. Wu, “Comparison of imaging techniques for tracking cardiac stem cell therapy,” Journal of Nuclear Medicine, vol. 48, no. 12, pp. 1916–1919, 2007. View at Publisher · View at Google Scholar · View at Scopus
  57. M. Gyöngyösi, J. Blanco, T. Marian et al., “Serial noninvasive in vivo positron emission tomographic tracking of percutaneously intramyocardially injected autologous porcine mesenchymal stem cells modified for transgene reporter gene expression,” Circulation: Cardiovascular Imaging, vol. 1, no. 2, pp. 94–103, 2008. View at Publisher · View at Google Scholar · View at Scopus
  58. J. Terrovitis, M. Stuber, A. Youssef et al., “Magnetic resonance imaging overestimates ferumoxide-labeled stem cell survival after transplantation in the heart,” Circulation, vol. 117, no. 12, pp. 1555–1562, 2008. View at Publisher · View at Google Scholar · View at Scopus
  59. A. S. Lee, D. Xu, J. R. Plews et al., “Preclinical derivation and imaging of autologously transplanted canine induced pluripotent stem cells,” The Journal of Biological Chemistry, vol. 286, no. 37, pp. 32697–32704, 2011. View at Publisher · View at Google Scholar · View at Scopus
  60. J. Liu, K. H. Narsinh, F. Lan et al., “Early stem cell engraftment predicts late cardiac functional recovery: preclinical insights from molecular imaging,” Circulation: Cardiovascular Imaging, vol. 5, no. 4, pp. 481–490, 2012. View at Publisher · View at Google Scholar · View at Scopus
  61. F. Lan, J. Liu, K. H. Narsinh et al., “Safe genetic modification of cardiac stem cells using a site-specific integration technique,” Circulation, vol. 126, no. 11, supplement 1, pp. S20–S28, 2012. View at Publisher · View at Google Scholar · View at Scopus
  62. C. Templin, R. Zweigerdt, K. Schwanke et al., “Transplantation and tracking of human-induced pluripotent stem cells in a pig model of myocardial infarction: assessment of cell survival, engraftment, and distribution by hybrid single photon emission computed tomography/computed tomography of sodium iodide symporter transgene expression,” Circulation, vol. 126, no. 4, pp. 430–439, 2012. View at Publisher · View at Google Scholar · View at Scopus
  63. X. Yan, P. Ray, R. Paulmurugan et al., “A transgenic tri-modality reporter mouse,” PLoS ONE, vol. 8, no. 8, Article ID e73580, 2013. View at Publisher · View at Google Scholar · View at Scopus
  64. Z. Pei, X. Lan, Z. Cheng et al., “Multimodality molecular imaging to monitor transplanted stem cells for the treatment of ischemic heart disease,” PLoS ONE, vol. 9, no. 3, Article ID e90543, 2014. View at Publisher · View at Google Scholar · View at Scopus
  65. A. R. Lee, S. K. Woo, S. K. Kang et al., “Adenovirus-mediated expression of human sodium-iodide symporter gene permits in vivo tracking of adipose tissue-derived stem cells in a canine myocardial infarction model,” Nuclear Medicine and Biology, vol. 42, no. 7, pp. 621–629, 2015. View at Publisher · View at Google Scholar
  66. V. Caveliers, G. De Keulenaer, H. Everaert et al., “In vivo visualization of 111In labeled CD133+ peripheral blood stem cells after intracoronary administration in patients with chronic ischemic heart disease,” Quarterly Journal of Nuclear Medicine and Molecular Imaging, vol. 51, no. 1, pp. 61–66, 2007. View at Google Scholar · View at Scopus
  67. M. Kurpisz, R. Czepczyński, B. Grygielska et al., “Bone marrow stem cell imaging after intracoronary administration,” International Journal of Cardiology, vol. 121, no. 2, pp. 194–195, 2007. View at Publisher · View at Google Scholar · View at Scopus
  68. R. Schots, G. De Keulenaer, D. Schoors et al., “Evidence that intracoronary-injected CD133+ peripheral blood progenitor cells home to the myocardium in chronic postinfarction heart failure,” Experimental Hematology, vol. 35, no. 12, pp. 1884–1890, 2007. View at Publisher · View at Google Scholar · View at Scopus
  69. V. Schächinger, A. Aicher, N. Döbert et al., “Pilot trial on determinants of progenitor cell recruitment to the infarcted human myocardium,” Circulation, vol. 118, no. 14, pp. 1425–1432, 2008. View at Publisher · View at Google Scholar · View at Scopus
  70. C. Dedobbeleer, D. Blocklet, M. Toungouz et al., “Myocardial homing and coronary endothelial function after autologous blood CD34+ progenitor cells intracoronary injection in the chronic phase of myocardial infarction,” Journal of Cardiovascular Pharmacology, vol. 53, no. 6, pp. 480–485, 2009. View at Publisher · View at Google Scholar · View at Scopus
  71. D. Blocklet, M. Toungouz, G. Berkenboom et al., “Myocardial homing of nonmobilized peripheral-blood CD34+ cells after intracoronary injection,” Stem Cells, vol. 24, no. 2, pp. 333–336, 2006. View at Publisher · View at Google Scholar · View at Scopus
  72. M. Hofmann, K. C. Wollert, G. P. Meyer et al., “Monitoring of bone marrow cell homing into the infarcted human myocardium,” Circulation, vol. 111, no. 17, pp. 2198–2202, 2005. View at Publisher · View at Google Scholar · View at Scopus
  73. W. J. Kang, H.-J. Kang, H.-S. Kim, J.-K. Chung, M. C. Lee, and D. S. Lee, “Tissue distribution of 18F-FDG-labeled peripheral hematopoietic stem cells after intracoronary administration in patients with myocardial infarction,” Journal of Nuclear Medicine, vol. 47, no. 8, pp. 1295–1301, 2006. View at Google Scholar
  74. E. Goussetis, A. Manginas, M. Koutelou et al., “Intracoronary infusion of CD133+ and CD133CD34+ selected autologous bone marrow progenitor cells in patients with chronic ischemic cardiomyopathy: cell isolation, adherence to the infarcted area, and body distribution,” Stem Cells, vol. 24, no. 10, pp. 2279–2283, 2006. View at Publisher · View at Google Scholar · View at Scopus
  75. M. Penicka, O. Lang, P. Widimsky et al., “One-day kinetics of myocardial engraftment after intracoronary injection of bone marrow mononuclear cells in patients with acute and chronic myocardial infarction,” Heart, vol. 93, no. 7, pp. 837–841, 2007. View at Publisher · View at Google Scholar · View at Scopus
  76. S. A. Silva, A. L. S. Sousa, A. F. Haddad et al., “Autologous bone-marrow mononuclear cell transplantation after acute myocardial infarction: comparison of two delivery techniques,” Cell Transplantation, vol. 18, no. 3, pp. 343–352, 2009. View at Publisher · View at Google Scholar · View at Scopus
  77. R. D. C. Moreira, A. F. Haddad, S. A. Silva et al., “Intracoronary stem-cell injection after myocardial infarction: microcirculation sub-study,” Arquivos Brasileiros de Cardiologia, vol. 97, no. 5, pp. 420–426, 2011. View at Publisher · View at Google Scholar · View at Scopus
  78. P. Musialek, L. Tekieli, M. Kostkiewicz et al., “Randomized transcoronary delivery of CD34+ cells with perfusion versus stop-flow method in patients with recent myocardial infarction: early cardiac retention of Tc99m-labeled cells activity,” Journal of Nuclear Cardiology, vol. 18, no. 1, pp. 104–116, 2011. View at Publisher · View at Google Scholar
  79. P. Musialek, L. Tekieli, M. Kostkiewicz et al., “Infarct size determines myocardial uptake of CD34+ cells in the peri-infarct zone: results from a study of Tc99m-extamatazime-labeled cells visualization integrated with cardiac magnetic resonance infarct imaging,” Circulation: Cardiovascular Imaging, vol. 6, no. 2, pp. 320–328, 2013. View at Publisher · View at Google Scholar
  80. L. M. Barbosa da Fonseca, S. S. Xavier, P. H. Rosado De Castro et al., “Biodistribution of bone marrow mononuclear cells in chronic chagasic cardiomyopathy after intracoronary injection,” International Journal of Cardiology, vol. 149, no. 3, pp. 310–314, 2011. View at Publisher · View at Google Scholar · View at Scopus
  81. N. Kollaros, A. Theodorakos, A. Manginas et al., “Bone marrow stem cell adherence into old anterior myocardial infarction: a scintigraphic study using Tl-201 and Tc-99m-HMPAO,” Annals of Nuclear Medicine, vol. 26, no. 3, pp. 228–233, 2012. View at Publisher · View at Google Scholar · View at Scopus
  82. B. Vrtovec, G. Poglajen, L. Lezaic et al., “Comparison of transendocardial and intracoronary CD34+ cell transplantation in patients with nonischemic dilated cardiomyopathy,” Circulation, vol. 128, no. 1, pp. S42–S49, 2013. View at Publisher · View at Google Scholar · View at Scopus
  83. F. Haddad, M. Sever, G. Poglajen et al., “Immunologic network and response to intramyocardial CD34+ stem cell therapy in patients with dilated cardiomyopathy,” Journal of Cardiac Failure, vol. 21, no. 7, pp. 572–582, 2015. View at Publisher · View at Google Scholar
  84. S. Roura, C. Gálvez-Montón, and A. Bayes-Genis, “Bioluminescence imaging: a shining future for cardiac regeneration,” Journal of Cellular and Molecular Medicine, vol. 17, no. 6, pp. 693–703, 2013. View at Publisher · View at Google Scholar · View at Scopus
  85. K. J. Ransohoff and J. C. Wu, “Advances in cardiovascular molecular imaging for tracking stem cell therapy,” Thrombosis and Haemostasis, vol. 104, no. 1, pp. 13–22, 2010. View at Publisher · View at Google Scholar · View at Scopus
  86. A. S. Arbab, B. Janic, J. Haller, E. Pawelczyk, W. Liu, and J. A. Frank, “In vivo cellular imaging for translational medical research,” Current Medical Imaging Reviews, vol. 5, no. 1, pp. 19–38, 2009. View at Publisher · View at Google Scholar · View at Scopus
  87. P. Hua, Y.-Y. Wang, L.-B. Liu et al., “In vivo magnetic resonance imaging tracking of transplanted superparamagnetic iron oxide-labeled bone marrow mesenchymal stem cells in rats with myocardial infarction,” Molecular Medicine Reports, vol. 11, no. 1, pp. 113–120, 2014. View at Publisher · View at Google Scholar · View at Scopus
  88. F. Callera and C. M. T. P. de Melo, “Magnetic resonance tracking of magnetically labeled autologous bone marrow CD34+ cells transplanted into the spinal cord via lumbar puncture technique in patients with chronic spinal cord injury: CD34+ cells' migration into the injured site,” Stem Cells and Development, vol. 16, no. 3, pp. 461–466, 2007. View at Publisher · View at Google Scholar · View at Scopus
  89. J. Zhu, L. Zhou, and F. X. Wu, “Tracking neural stem cells in patients with brain trauma,” The New England Journal of Medicine, vol. 355, no. 22, pp. 2376–2378, 2006. View at Publisher · View at Google Scholar · View at Scopus
  90. I. J. M. de Vries, W. J. Lesterhuis, J. O. Barentsz et al., “Magnetic resonance tracking of dendritic cells in melanoma patients for monitoring of cellular therapy,” Nature Biotechnology, vol. 23, no. 11, pp. 1407–1413, 2005. View at Publisher · View at Google Scholar · View at Scopus
  91. C. Toso, J.-P. Vallee, P. Morel et al., “Clinical magnetic resonance imaging of pancreatic islet grafts after iron nanoparticle labeling,” American Journal of Transplantation, vol. 8, no. 3, pp. 701–706, 2008. View at Publisher · View at Google Scholar · View at Scopus
  92. T. J. England, M. Abaei, D. P. Auer et al., “Granulocyte-colony stimulating factor for mobilizing bone marrow stem cells in subacute stroke: the stem cell trial of recovery enhancement after stroke 2 randomized controlled trial,” Stroke, vol. 43, no. 2, pp. 405–411, 2012. View at Publisher · View at Google Scholar · View at Scopus
  93. E. Farrell, P. Wielopolski, P. Pavljasevic et al., “Effects of iron oxide incorporation for long term cell tracking on MSC differentiation in vitro and in vivo,” Biochemical and Biophysical Research Communications, vol. 369, no. 4, pp. 1076–1081, 2008. View at Publisher · View at Google Scholar · View at Scopus
  94. H. S. Kim, S. Y. Oh, H. J. Joo, K.-R. Son, I.-C. Song, and W. K. Moon, “The effects of clinically used MRI contrast agents on the biological properties of human mesenchymal stem cells,” NMR in Biomedicine, vol. 23, no. 5, pp. 514–522, 2010. View at Publisher · View at Google Scholar · View at Scopus
  95. Jasmin, A. L. M. Torres, L. Jelicks, A. C. C. De Carvalho, D. C. Spray, and R. Mendez-Otero, “Labeling stem cells with superparamagnetic iron oxide nanoparticles: analysis of the labeling efficacy by microscopy and magnetic resonance imaging,” Methods in Molecular Biology, vol. 906, pp. 239–252, 2012. View at Publisher · View at Google Scholar · View at Scopus
  96. Jasmin, A. L. M. Torres, H. M. P. Nunes et al., “Optimized labeling of bone marrow mesenchymal cells with superparamagnetic iron oxide nanoparticles and in vivo visualization by magnetic resonance imaging,” Journal of Nanobiotechnology, vol. 9, article 4, 2011. View at Publisher · View at Google Scholar · View at Scopus
  97. D. Hou, E. A.-S. Youssef, T. J. Brinton et al., “Radiolabeled cell distribution after intramyocardial, intracoronary, and interstitial retrograde coronary venous delivery: implications for current clinical trials,” Circulation, vol. 112, no. 9, pp. I150–I156, 2005. View at Publisher · View at Google Scholar · View at Scopus
  98. S. H. Ranganath, O. Levy, M. S. Inamdar, and J. M. Karp, “Harnessing the mesenchymal stem cell secretome for the treatment of cardiovascular disease,” Cell Stem Cell, vol. 10, no. 3, pp. 244–258, 2012. View at Publisher · View at Google Scholar · View at Scopus
  99. U. M. Fischer, M. T. Harting, F. Jimenez et al., “Pulmonary passage is a major obstacle for intravenous stem cell delivery: the pulmonary first-pass effect,” Stem Cells and Development, vol. 18, no. 5, pp. 683–691, 2009. View at Publisher · View at Google Scholar · View at Scopus
  100. R. H. Lee, A. A. Pulin, M. J. Seo et al., “Intravenous hMSCs improve myocardial infarction in mice because cells embolized in lung are activated to secrete the anti-inflammatory protein TSG-6,” Cell Stem Cell, vol. 5, no. 1, pp. 54–63, 2009. View at Publisher · View at Google Scholar · View at Scopus